Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis - Scorecard - MDSpire

Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis

  • By

  • Zengwei Li

  • Tingfei Song

  • Yu Zhang

  • Yonghui Wang

  • Hui Sun

  • June 18, 2026

  • 0 min

Share

Clinical Scorecard: Thyroid Function and Endocrine Treatment in Early Luminal Breast Cancer: A Controlled Longitudinal Retrospective Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with early luminal breast cancer receiving adjuvant endocrine therapy without prior chemotherapy or radiotherapy.
Care Setting

Key Highlights

  • subgroup_analysis

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • R
      • e
      • g
      • u
      • l
      • a
      • r
      • t
      • h
      • y
      • r
      • o
      • i
      • d
      • f
      • u
      • n
      • c
      • t
      • i
      • o
      • n
      • t
      • e
      • s
      • t
      • s
      • s
      • h
      • o
      • u
      • l
      • d
      • b
      • e
      • c
      • o
      • n
      • d
      • u
      • c
      • t
      • e
      • d
      • a
      • t
      • b
      • a
      • s
      • e
      • l
      • i
      • n
      • e
      • ,
      • 1
      • y
      • e
      • a
      • r
      • ,
      • a
      • n
      • d
      • 3
      • y
      • e
      • a
      • r
      • s
      • p
      • o
      • s
      • t
      • -
      • s
      • u
      • r
      • g
      • e
      • r
      • y
      • ,
      • a
      • n
      • d
      • c
      • o
      • n
      • s
      • i
      • d
      • e
      • r
      • a
      • d
      • d
      • i
      • t
      • i
      • o
      • n
      • a
      • l
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • i
      • f
      • a
      • b
      • n
      • o
      • r
      • m
      • a
      • l
      • i
      • t
      • i
      • e
      • s
      • a
      • r
      • e
      • d
      • e
      • t
      • e
      • c
      • t
      • e
      • d
      • .

      Risks

        Patient & Prescribing Data

        Adjuvant tamoxifen or aromatase inhibitors (specify types) were used without prior chemotherapy or radiotherapy.

        Clinical Best Practices

        • recommendations

        Related Resources & Content

        Original Source(s)

        Related Content